Interdisciplinary training to develop talent
The quality of our teams is key to the success of our projects. Facilitating access to high-level training is a key factor in the development of innovation. The PSCC relies on three components to develop talent:
-
The OncoEntrepreneur program,
-
catalogue of high-level training courses,
-
Talent development.
OncoEntrepreneur program
A programme dedicated to pre-creation projects and recent start-ups, led by the PSCC and facilitated by ecosystem experts, to give entrepreneurs all the keys they need to make a success of their oncology project.
Access to high-level training catalogues
The PSCC gives supported projects access, as free auditors, to academic training courses (modules offered by Université Paris-Saclay, Institut Polytechnique de Paris and Gustave Roussy) in several key areas: intellectual property, regulatory affairs, market access, artificial intelligence, biomedical engineering, pharmacochemistry, and so on. These courses provide innovative project teams with high-level training, while offering opportunities for interaction with students and researchers who could potentially become future talent for start-ups.
Talent development
The PSCC fosters the development of an entrepreneurial culture by encouraging young people to take the plunge into entrepreneurship through meetings or by encouraging internships, doctorates or post-docs within PSCC Connect companies.
For whom & what kind of project?
The programme is aimed at all Oncology project leaders (researchers, clinicians, students and entrepreneurs) at an early stage: before start-up creation or for start-ups in the development phase. - The programme consists of a common core and additional training courses specifically designed for Biotech, s, Medtechs and e-health companies. - The programme is 100% funded by the PSCC.
Selected projects:
Benefit from 25 masterclasses (2h/week for 7 months) covering the key issues involved in setting up a company, as well as the specificities of oncology: shareholder agreements, intellectual property, regulatory and tax issues, partnerships, preclinical and clinical trials, fundraising, market access... Also receive help in preparing pitches and feedback from experts. This PSCC programme contributes to the OncoSTART collective's “toolbox” for cancer entrepreneurship.
Why apply?
You will benefit from a comprehensive overview of the challenges and steps you need to anticipate to make a success of your innovative oncology project. You will develop your network by meeting high-level speakers with varied profiles (experts, consultants, patient associations, investors, etc.). You will have the opportunity to make new contacts with other project leaders and share your experiences (meetings on the cluster site).
Submission of applications
Submission of applications
From July 15 to October 25, 2024
Selection
By the selection committee & announcement to candidates.
November 12, 2024
Masterclass
(2h/week in hybrid mode) + networking
December 3, 2024 to June 24, 2025
Final pitch
In front of a panel of experts
July 8, 2025
Replay of the presentation webinar (September 17, 2024) with Alice De Queylard, PSCC Director of Operations and Nouzha Salah-Mohellibi, PSCC Ecosystem Manager.
Juan Pablo de la Plata Alcalde, Visionerves (Paris region) i-Lab 2024 winning project
« I appreciated the network, the contacts with experts and the hybrid mode of the Masterclasses. »
Charly HELAINE (project Nanozeoxy)
« The Masterclasses of the PSCC's OncoEntrepreneur program programme enable us to understand all the essential aspects (scientific, technical, regulatory, commercial and financial ...) of creating a biotech and developing it from pre-clinical to clinical. Participation in the OncoEntrepreneur programmeprogram helped us to better understand and structure our project for the iPhD innovation competition, for which the project was a winner in 2024. »
Emile Roussel and Lise Clément-Demange (REACT Therapeutics project, i-LAB2024 winner)
« The Masterclasses in the OncoEntrepreneur programme offer the key elements for refining the entrepreneurial vision and better understanding the scientific, technical, commercial and financial aspects of a biotech. »
Eya ALOUI (ALBUPAD project, i-Lab 2024 winner)
« OncoEntrepreneur has given me an in-depth understanding of the regulatory and clinical issues involved in developing extended delivery solutions for cancer therapies. This will enable us to successfully implement the innovation program programme planned as part of the i-Lab winning ALBUPAD2024 project. »
Frédéric Zampatti, Algenscribe (Nice)
« The program programme covers all the issues that a young innovative company may encounter, with a factual approach to the problems to be anticipated. »
To join the OncoEntrepreneur training programme (2025/26 class), apply in summer 2025.
The oncoentrepreneur program
Launched in 2014 by Cancer Campus, the “OncoEntrepreneur” programme trains innovative project leaders at an early stage. The Paris Saclay Cancer Cluster has been piloting and leading this programme since 2022 to encourage and support entrepreneurship in oncology.
